Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women
Evaluation of the Aromatase Inhibition Potential of Standardized Grape Extract
RATIONALE: Estrogen can cause the growth of breast cancer cells. Studying samples of blood and urine in the laboratory from participants receiving freeze-dried table grape powder may help doctors understand the effect of this drug on blood estrogen levels.
PURPOSE: This clinical trial is studying the effect of freeze-dried table grape powder on blood estrogen levels in postmenopausal women.
研究概览
详细说明
OBJECTIVES:
- To measure the change in levels of plasma estrone (E1), estradiol, E1-conjugates, and E1-sulfates in postmenopausal women after 6 weeks of daily ingestion of 94 grams of freeze-dried table grape powder.
- To conduct bioavailability research on the freeze-dried table grape powder in humans through the analysis of participants' blood and urine samples.
OUTLINE: Participants receive oral freeze-dried table grape powder once daily on days 1-42 in addition to their usual diet. Treatment continues in the absence of toxicity.
Participants undergo blood sample collection at baseline, periodically after the first dose, and on the last day of the study for pharmacokinetic and bioavailability analysis. Samples are examined by mass spectrometry to measure plasma levels of estrone (E1), estradiol, E1-conjugates, E1-sulfates, testosterone, and androstenedione. Participants also undergo spot urine collection and weight and height measurement periodically during study.
Participants complete food diaries on days 1-3, 21-23, and 40-42 to assess their intake of grapes, grape juice, and red wine and to examine the constancy of their caloric intake over the course of the study.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Minnesota
-
Rochester、Minnesota、美国、55905
- Mayo Clinic
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
PATIENT CHARACTERISTICS:
- ECOG performance status 0-1
- Female
- Postmenopausal (defined as women who have had both ovaries removed or no menstrual period for at least 12 consecutive months)
- Able to give informed consent and complete food records alone or with assistance
描述
DISEASE CHARACTERISTICS:
Participant in the Mayo Mammography Health Study
- Has consented to provide baseline mammogram for digitization
PATIENT CHARACTERISTICS:
- ECOG performance status 0-1
- Female
- Postmenopausal (defined as women who have had both ovaries removed or no menstrual period for at least 12 consecutive months)
- Able to give informed consent and complete food records alone or with assistance
- Willing to provide research blood and urine samples
- Must be a non-smoker
- Willing to maintain current weight
- No history of breast ductal carcinoma in situ or any other cancer, except basal cell or squamous cell skin cancer or lobular carcinoma in situ
- No history of allergic or other adverse reaction to grapes
- No history of diabetes or glucose intolerance
PRIOR CONCURRENT THERAPY:
- No concurrent hormone therapy, including estradiol, estrone, or progestins
学习计划
研究是如何设计的?
设计细节
- 观测模型:病例对照
- 时间观点:预期
研究衡量的是什么?
主要结果指标
结果测量 |
|---|
|
Serum levels of plasma estrone (E1), estradiol, E1-conjugates, and E1-sulfates
|
|
Bioavailability of the freeze-dried table grape powder in humans
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.